Sofinnova Investments, Inc. Kala Pharmaceuticals, Inc. Transaction History

Sofinnova Investments, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$7.5 - $11.11 $3.8 Million - $5.63 Million	-506,647 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$8.33 - $13.79 $5.06 Million - $8.38 Million	-607,873 Reduced 54.54%	506,647 $5.33 Million
Q1 2020 May 13, 2020	BUY	$3.83 - $8.79 $1.72 Million - $3.95 Million	449,879 Added 67.69%	1,114,520 $9.8 Million
Q4 2019 Feb 14, 2020	BUY	$3.36 - $4.81 $626,421 - $896,752	186,435 Added 38.99%	664,641 $2.45 Million
Q3 2019 Nov 14, 2019	BUY	$3.57 - $6.58 $646,012 - $1.19 Million	180,956 Added 60.88%	478,206 $1.82 Million

Q2 2019 Aug 13, 2019	SELL	$4.93 - $8.8 $237,113 - $423,244	-48,096 Reduced 13.93%	297,250 $1.9 Million
Q1 2019 May 15, 2019	SELL	$5.19 - $8.97 $519,882 - $898,524	-100,170 Reduced 22.48%	345,346 $2.86 Million
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $1.5 Million - $3.48 Million	349,861 Added 365.75%	445,516 $2.18 Million
Q3 2018 Nov 15, 2018	SELL	$9.54 - $13.87 $1.98 Million - $2.88 Million	-207,721 Reduced 68.47%	95,655 $944,000
Q2 2018 Nov 15, 2018	BUY	$13.3 - $17.49 $3.61 Million - $4.74 Million	271,128 Added 840.76%	303,376 $4.17 Million
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.49 $157,458 - $207,064	11,839 Added 58.01%	32,248 $443,000
Q1 2018 May 15, 2018	BUY	$12.26 - $18.98 $250,214 - $387,362	20,409 New	20,409 $323,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.